Zimmer Biomet publishes 2025 annual report, posts $8.232 billion net sales, up 7%

Zimmer Biomet Holdings, Inc. -0.15%

Zimmer Biomet Holdings, Inc.

ZBH

90.89

-0.15%

  • Zimmer Biomet annual report for fiscal 2025 highlighted stronger sales momentum, supported by acquisitions, market growth, new product launches.
  • Integration work advanced on Paragon 28, Monogram Technologies, OrthoGrid, expanding presence in faster-growing segments such as foot and ankle, robotics.
  • U.S. commercial model entered transition phase, with multi-year shift from independent sales agents to employees to build a more specialized sales channel.
  • Tariffs weighed on results, while portfolio rationalization drove inventory and instrument charges tied to product lines slated for discontinuation.
  • Direct-to-patient marketing expanded in 2025, aiming to lift awareness of knee offerings through campaigns featuring Arnold Schwarzenegger.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zimmer Biomet Holdings Inc. published the original content used to generate this news brief on April 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.